Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Maggioni

Showing results (91-100 of 109) with videos related to

Pageof 11
Sort By:
Hepatology (Baltimore, Md.)|March 31, 2015
Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patientsMarta Milano, Alessio Aghemo, Rosellina Margherita Mancina, et al.
Journal of Hepatology|May 19, 2015
Statin use and non-alcoholic steatohepatitis in at risk individualsPaola Dongiovanni, Salvatore Petta, Ville Mannisto, et al.
Plos One|July 7, 2011
Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinomaFederico Colombo, Francesca Baldan, Silvia Mazzucchelli, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2019
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without SteatohepatitisSerena Pelusi, Annalisa Cespiati, Raffaela Rametta, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 28, 2023
Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decadesRosa Lombardi, Lucia Colavolpe, Francesca Alletto, et al.
Journal of Hepatology|November 25, 2015
MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver diseaseSalvatore Petta, Luca Valenti, Fabio Marra, et al.
The Journal of Clinical Endocrinology and Metabolism|May 5, 2017
Fibronectin Type III Domain-Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseSalvatore Petta, Luca Valenti, Gianluca Svegliati-Baroni, et al.
Nature Communications|October 16, 2025
Chromatin remodeling restrains oncogenic functions in prostate cancerValentina Rosti, Giovanni Lembo, Cristiano Petrini, et al.
Cells|March 11, 2023
Human Bone Marrow-Derived Mesenchymal Stromal Cells Reduce the Severity of Experimental Necrotizing Enterocolitis in a Concentration-Dependent MannerLivia Provitera, Andrea Tomaselli, Genny Raffaeli, et al.
The American Journal of Gastroenterology|May 27, 2020
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver DiseaseRamy Younes, Olivier Govaere, Salvatore Petta, et al.
Pageof 11

Showing results (91-100 of 109) with videos related to

Sort By:
Pageof 11
Hepatology (Baltimore, Md.)|March 31, 2015
Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patientsMarta Milano, Alessio Aghemo, Rosellina Margherita Mancina, et al.
Journal of Hepatology|May 19, 2015
Statin use and non-alcoholic steatohepatitis in at risk individualsPaola Dongiovanni, Salvatore Petta, Ville Mannisto, et al.
Plos One|July 7, 2011
Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinomaFederico Colombo, Francesca Baldan, Silvia Mazzucchelli, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2019
Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without SteatohepatitisSerena Pelusi, Annalisa Cespiati, Raffaela Rametta, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 28, 2023
Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decadesRosa Lombardi, Lucia Colavolpe, Francesca Alletto, et al.
Journal of Hepatology|November 25, 2015
MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver diseaseSalvatore Petta, Luca Valenti, Fabio Marra, et al.
The Journal of Clinical Endocrinology and Metabolism|May 5, 2017
Fibronectin Type III Domain-Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseSalvatore Petta, Luca Valenti, Gianluca Svegliati-Baroni, et al.
Nature Communications|October 16, 2025
Chromatin remodeling restrains oncogenic functions in prostate cancerValentina Rosti, Giovanni Lembo, Cristiano Petrini, et al.
Cells|March 11, 2023
Human Bone Marrow-Derived Mesenchymal Stromal Cells Reduce the Severity of Experimental Necrotizing Enterocolitis in a Concentration-Dependent MannerLivia Provitera, Andrea Tomaselli, Genny Raffaeli, et al.
The American Journal of Gastroenterology|May 27, 2020
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver DiseaseRamy Younes, Olivier Govaere, Salvatore Petta, et al.
Pageof 11